In total, there are about 50 student volunteers, along with an additional 350 volunteers registered to work on an ad hoc ...

The annual meeting of the American Diabetes Association was held this year from June 20 to 23 in Chicago, drawing more than ...

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction ...

Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...

A new study published June 25 in the Journal of the American Heart Association finds that fewer people are dying ... particularly obesity and diabetes, so we shouldn’t write everything off to age ...

Amgen (NASDAQ:AMGN) today announced full results from Part 1 of the Phase 2 study of MariTide (maridebart cafraglutide, formerly AMG 133), a long-acting, peptide-antibody conjugate subcutaneously ...

Eli Lilly & Co.’s experimental weight-loss pill helped patients shed pounds without serious side effects in a clinical trial, burnishing the drug’s blockbuster potential in the company’s competition ...

CHICAGO, June 21, 2025 /PRNewswire/ -- As the American Diabetes Association ® (ADA) celebrates its 85 th anniversary, it continues to fuel transformative progress in the fight to end diabetes ...

By American Diabetes Association Jun 20, 2025 Updated Jun 20, 2025 ...

Cardiovascular Efficacy of Evolocumab in Persons with Type 1 Diabetes Mellitus: Insights from FOURIER Trial Abstract #1991, Abstract Session: Sunday, June 22 from 12:30 p.m. - 1:30 p.m. CDT ...

JIANGSU, China and BOSTON, June 16, 2025 (GLOBE NEWSWIRE) -- Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui), a global pharmaceutical company focused on scientific and technological innovation, ...